<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02395003</url>
  </required_header>
  <id_info>
    <org_study_id>1503015459</org_study_id>
    <secondary_id>2R01HD028016-20A1</secondary_id>
    <secondary_id>2R01HD028016</secondary_id>
    <nct_id>NCT02395003</nct_id>
  </id_info>
  <brief_title>Study to Investigate Adipocyte Cell and Lipid Turnover in Obese Adolescents</brief_title>
  <official_title>Study to Investigate Adipocyte Cell and Lipid Turnover in Obese Adolescents</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Yale University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Yale University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Insulin Resistance is the best predictor of whether the obese adolescent will develop type 2
      diabetes. The present studies will focus on determining what might cause fat to accumulate in
      the subcutaneous fat regions and lead to local inflammation, causing insulin resistance to
      develop in obese adolescents.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The purpose of this study is to test whether the reduced transcription of key
      lipogenic/adipogenic genes in abdominal subcutaneous adipose tissue (SAT) in obese
      adolescents with a High VAT/SAT (visceral adipose tissue/subcutaneous adipose tissue) ratio
      translates functionally into a reduced in vivo triglyceride (TG) synthesis and adipocyte
      proliferation, which in turn will contribute to ectopic fat accumulation and insulin
      resistance (IR). To test whether the storage capacity of gluteal SAT is linked to the level
      of VAT/SAT fat distribution in obese adolescents. To explore if changes in dietary fat intake
      (palmitate intake), alters ceramide concentration in both plasma and adipose tissue (AT) and
      the Inflammasome complex in the different fat distribution phenotypes and their associations
      with IR.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>April 2016</start_date>
  <completion_date type="Anticipated">November 2025</completion_date>
  <primary_completion_date type="Anticipated">May 2025</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>12 Weeks</target_duration>
  <primary_outcome>
    <measure>Fat Biopsies</measure>
    <time_frame>Baseline</time_frame>
    <description>1) To test whether the reduced transcription of key lipogenic/adipogenic genes in abd SAT in obese adolescents with a High VAT/SAT ratio translates functionally into a reduced in vivo TG synthesis and adipocyte proliferation, which in turn will contribute to ectopic fat accumulation and IR.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>MRI</measure>
    <time_frame>Baseline</time_frame>
    <description>Visceral to Subcutaneous fat storage ratio</description>
  </secondary_outcome>
  <number_of_groups>4</number_of_groups>
  <enrollment type="Actual">104</enrollment>
  <condition>Pediatric Obesity</condition>
  <arm_group>
    <arm_group_label>High VAT/SAT high Palmitate Diet</arm_group_label>
    <description>Subjects with a high ratio of visceral to subcutaneous fat consuming high Palmatite oil diet for 12 weeks</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Low VAT/SAT</arm_group_label>
    <description>Subjects with a low ratio of visceral to subcutaneous fat</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Lean Controls</arm_group_label>
    <description>Lean control</description>
  </arm_group>
  <arm_group>
    <arm_group_label>High VAT/SAT- low Palmitate Diet</arm_group_label>
    <description>Subjects with a high ratio of visceral to subcutaneous fat consuming low Palmatite oil diet for 12 weeks</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Palmitate Diet</intervention_name>
    <description>Subject with high VAT/SAT ratio will be randomized to a high or low palmitate oil diet.</description>
    <arm_group_label>High VAT/SAT high Palmitate Diet</arm_group_label>
    <arm_group_label>Low VAT/SAT</arm_group_label>
  </intervention>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Basal plasma samples for measurements of glucose and glycerol enrichment, and glucose,
      insulin FFAs, leptin, C-peptide, glucagon, adiponectin, cortisol, growth hormone,
      catecholamines and amino acids, will be collected.
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Obese adolescents
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Overweight (85-95th% age and gender specific) or Obese (&gt;95th% age and gender
             specific)

          -  Ages 12-18 years

          -  Absence of any endocrinopathy

          -  Absence of any therapy with medication known to alter glucose metabolism (i.e.: Oral
             steroids, certain psychiatric medications such as Xeleca, Lithium, Paxil)

          -  English Speaking subjects

        Exclusion Criteria:

          -  Any disease known to alter glucose metabolism (T2DM)

          -  Diuretic Medication

          -  Pregnant or breastfeeding

          -  Type 1 or 2 diabetes
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>12 Years</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sonia Caprio, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Yale University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Yale</name>
      <address>
        <city>New Haven</city>
        <state>Connecticut</state>
        <zip>06511</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>March 16, 2015</study_first_submitted>
  <study_first_submitted_qc>March 19, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 20, 2015</study_first_posted>
  <last_update_submitted>April 14, 2020</last_update_submitted>
  <last_update_submitted_qc>April 14, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">April 16, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Obesity</keyword>
  <keyword>Pediatric</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pediatric Obesity</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

